1. Developmental Biology
  2. Immunology and Inflammation

Single-cell transcriptomics reveals functionally specialized vascular endothelium in brain

  1. Hyun-Woo Jeong  Is a corresponding author
  2. Rodrigo Diéguez-Hurtado
  3. Hendrik Arf
  4. Jian Song
  5. Hongryeol Park
  6. Kai Kruse
  7. Lydia Sorokin
  8. Ralf H Adams  Is a corresponding author
  1. Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, Germany
  2. Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, Germany
  3. Cells-in-Motion Interfaculty Centre (CiMIC), University of Münster, Germany
https://doi.org/10.7554/eLife.57520
Share this article
Cite this article
  1. Hyun-Woo Jeong
  2. Rodrigo Diéguez-Hurtado
  3. Hendrik Arf
  4. Jian Song
  5. Hongryeol Park
  6. Kai Kruse
  7. Lydia Sorokin
  8. Ralf H Adams
(2022)
Single-cell transcriptomics reveals functionally specialized vascular endothelium in brain
eLife 11:e57520.
https://doi.org/10.7554/eLife.57520
  2. Download BibTeX
  3. Download .RIS

Abstract

The blood-brain barrier (BBB) limits the entry of leukocytes and potentially harmful substances from the circulation into the central nervous system (CNS). While BBB defects are a hallmark of many neurological disorders, the cellular heterogeneity at the neurovascular interface, and the mechanisms governing neuroinflammation are not fully understood.

Through single-cell RNA sequencing of non-neuronal cell populations of the murine cerebral cortex during development, adulthood, ageing, and neuroinflammation, we identify reactive endothelial venules, a compartment of specialized postcapillary endothelial cells that are characterized by consistent expression of cell adhesion molecules, preferential leukocyte transmigration, association with perivascular macrophage populations, and endothelial activation initiating CNS immune responses. Our results provide novel insights into the heterogeneity of the cerebral vasculature and a useful resource for the molecular alterations associated with neuroinflammation and ageing.

Editor's evaluation

This study provides insight into an understudied cell type in the neurovascular unit involved in inflammatory disease and provides a resource of scRNA seq data for non-neuronal CNS cells. Further, it provides some interesting areas for future investigations into neuroimmune mechanisms used by the brain vasculature to control leukocyte transmigration in various health and disease conditions. This work will be of interest to vascular and neurovascular biologists, aging biologists, immunologists, and translational/clinical scientists interested in disease therapies.

https://doi.org/10.7554/eLife.57520.sa0

Introduction

The blood-brain barrier (BBB) controls the entry of a wide range of molecules from the circulation into the central nervous system (CNS) and thereby maintains the appropriate chemical and cellular composition of the neuronal ‘milieu’, which is required for the correct function of synapses and neuronal circuits (Zlokovic, 2008; Zlokovic, 2010). The BBB also protects the brain against the entry of leukocytes and potentially harmful substances, a function that is compromised in conditions such as multiple sclerosis, cancer, after stroke, or in response to physical brain damage (Arvanitis et al., 2020; Lopes Pinheiro et al., 2016; Thal and Neuhaus, 2014). The neurovascular unit, the anatomical structure underlying the BBB, comprised different cell types including endothelial cells (ECs), pericytes, and astrocytes, which are all located in close proximity and presumably affect each other through reciprocal interactions (Armulik et al., 2011; Liebner et al., 2018).

Previous work has established that leukocyte extravasation – the exit from the blood stream into the tissue – generally occurs in postcapillary venules of the skin, muscle, and mesentery, whereas in lung and liver this process is confined to microcapillaries (Strell and Entschladen, 2008). Even in the absence of neuroinflammation, peripherally activated circulating T cells can cross the endothelium of postcapillary vessels and reach the adjacent subarachnoid space. Here, T cells can encounter tissue resident antigen-presenting cells (APCs), but they are unable to traverse the astrocytic basement membrane and glia limitans (Mapunda et al., 2022). In the absence of cognate antigen presented by APCs, T cells undergo apoptosis or re-enter the circulation (Mastorakos and McGavern, 2019). Accordingly, immune surveillance and the initiation of CNS immune responses are highly dependent on the cellular and molecular components of the postcapillary venules and the perivascular environment, but we currently lack a comprehensive understanding of the underlying molecular mechanisms.

Transcriptional profiling has recently provided important insights into the cellular composition of the CNS and the arterial-venous zonation of brain vessels during postnatal development and adult homeostasis (Sabbagh et al., 2018; Vanlandewijck et al., 2018; Zeisel et al., 2015). On the other hand, brain ECs demonstrate similar gene expression changes in various BBB dysfunction models, suggesting a common mechanism for compromised BBB function throughout different neurological disorders (Munji et al., 2019). Despite these important insights, the molecular heterogeneity of vascular cells and their dynamic modulation, which is critical for BBB function (Villabona-Rueda et al., 2019), remains insufficiently understood. One critical technical issue is the low abundance of vascular cells relative to neural cell types in the brain.

In this study, we have established a protocol for the depletion of neurons and oligodendrocytes prior to droplet-based single-cell transcriptome analysis of non-neuronal cells in mouse cerebral cortex. We have generated a comprehensive resource of vascular gene expression at single-cell resolution during postnatal development, adulthood, ageing, and in the demyelinating neuroinflammatory condition of experimental autoimmune encephalomyelitis (EAE), a mouse model of human multiple sclerosis (Ben-Nun et al., 2014). This resulting data, which can be interrogated at single-cell.mpi-muenster.mpg.de, provides useful insights into the cellular and molecular heterogeneity of blood vessels in brain and permits identification of functionally specialized reactive postcapillary venules (REVs), which we propose to regulate the infiltration of activated leukocytes during neuroinflammation. Using a computational framework, we have also constructed a detailed cell-to-cell intercommunication map of the brain vasculature.

Results

Single-cell RNA-sequencing of non-neuronal cell population in mouse cerebral cortex

To enrich vascular and vessel wall-associated cell types while preserving the heterogeneity of these populations, we depleted myelin-associated neurons and oligodendrocytes, the most abundant cell types in CNS, using a bovine serum albumin (BSA)-gradient method (Figure 1—figure supplement 1A, B). Following quality control and data trimming (Figure 1—figure supplement 1C), a total of 29,406 single cells from three different postnatal ages, juvenile (10,796 cells, postnatal day 10), adult (9871 cells, 7–11 weeks), and aged (8739 cells, 18 months) were analyzed further (Figure 1—figure supplement 2A). Analysis by a nonlinear dimensionality reduction technique, uniform manifold approximation and projection (UMAP) (Figure 1A–C), and unsupervised hierarchical clustering (Figure 1D and E) established six different non-neuronal cell types, namely ECs, microglia (Micro), astroependymal cells (Astro), perivascular macrophages (PVMs), mural cells (Mural), and cerebral fibroblast-like cells (Fibro). Each cell type was successfully annotated by known marker genes such as Flt1 for ECs, Tmem119 for microglia, Folr1 for astroependymal cells, Mrc1 for PVMs, Rgs5 for mural cells, and Nov for the Fibro population (Figure 1E and F). All these markers are expressed specifically and continuously in all age groups analyzed (Figure 1—figure supplement 2B-D).

Figure 1 with 2 supplements see all
Download asset Open asset
Single-cell RNA-seq analysis of non-neuronal cell types in mouse cerebral cortex.

(A) Uniform manifold approximation and projection (UMAP) plot of 29,406 myelin-depleted single cells from murine cerebral cortex. Colors represent endothelial cells (EC), microglia (Micro), astroependymal cells (Astro), perivascular macrophage (PVM), mural cell (Mural), and cerebral fibroblast (Fibro). (B) Split UMAP plots showing separated cells from juvenile, adult, and aged samples, respectively. (C) Bar plots show the relative frequency of cell types for each age. (D) Dendrogram describing the taxonomy of all identified non-neuronal cell types. (E) Heatmap indicates the top 50 marker genes for each cell type. (F) Expression distribution of the top marker genes for each cell type projected onto the UMAP plot. Color represents the scaled expression level.

Figure 1—source data 1

Source data for Figure 1C.

https://cdn.elifesciences.org/articles/57520/elife-57520-fig1-data1-v2.xlsx

Unsupervised clustering reveals a diversity of EC subtypes

To gain insight into the heterogeneity of vascular and perivascular cell types, we first analyzed ECs during postnatal development using UMAP dimensionality reduction. Juvenile ECs were annotated to six different subclusters corresponding to arterial, capillary/precapillary arteriolar (CapA), capillary/postcapillary venular (CapV), venous, mitotic, and tip ECs (Figure 2—figure supplement 1A, B). Trajectory analysis indicates that there are one mitotic axis (M) and a tip cell axis (T), which are closely associated with venous populations (V), whereas arterial ECs (A) are found in a different branch of polarization (Figure 2—figure supplement 1C). Distinct transcriptional profiles reveal the expression of venous genes in tip and mitotic ECs (Figure 2—figure supplement 1D, E), while these two populations are also distinguished by specifically expressed transcripts such as Mcam for tip cells and Top2a for mitotic cells (Figure 2—figure supplement 1F). Pseudotime reconstruction analysis reveals a continuum of venous-to-arterial gene expression and also confirmed the presence of venous attributes in tip and mitotic ECs (Figure 2—figure supplement 1G-J), consistent with previous findings that tip and mitotic ECs emerge from veins and are, in part, incorporated into arteries (Pitulescu et al., 2017; Xu et al., 2014).

Next, we analyzed adult and aged EC populations. Although there was no striking change in gene expression profiles between adult and aged ECs (Spearman’s correlation coefficient = 0.9852), 407 genes were identified as differentially expressed (Padj <0.001, Figure 2—figure supplement 2A). Gene set enrichment analysis (GSEA) indicates that genes related to ECM-receptor interaction, focal adhesion, and the P53 signalling pathway are enriched in adult ECs, while genes related to cell adhesion molecules, chemokine signalling, and T cell receptor signalling are enriched in aged ECs (Figure 2—figure supplement 2B, C), indicating that ECs undergo molecular changes toward a proinflammatory state during ageing, which is consistent with recently published work (Chen et al., 2020).

To investigate EC subtypes during homeostasis, we performed subclustering analysis of adult and aged ECs together. As expected, tip and mitotic EC populations are largely absent in these samples, whereas venous, CapV, CapA, and arterial ECs are clearly segregated (Figure 2A and B and Figure 2—figure supplement 3A, B). Interestingly, we found one additional minor but distinctive subpopulation of venous ECs (Figure 2A and B; boxed area), which we subsequently termed REV. These ECs are characterized by the expression of Icam1 and Vcam1, encoding intercellular adhesion molecules (ICAMs), and the endothelial activation or dysfunction markers Vwf and Irf1 (Figure 2C and D). It has been reported that endothelial expression of ICAM-1 is essential for transcellular diapedesis (Abadier et al., 2015) but is suppressed by sonic hedgehog signalling in the CNS during homeostasis, thereby limiting infiltration of circulating inflammatory leukocytes through the BBB (Alvarez et al., 2011). However, the small subpopulation of venous ECs we found from the single-cell transcriptome data shows consistent expression of Icam1 even in immunologically naïve conditions both in adult and aged mice (Figure 2D and E). To further characterize the Icam1-expressing REVs, we performed gene ontology (GO) term enrichment analysis and revealed that 663 genes (Padj <0.05) predominantly expressed in this cell population were significantly enriched in biological processes involving inflammatory/immune responses, cell adhesion, and leukocyte migration and adhesion (Figure 2F). An alternative, nonlinear dimensionality reduction method called Markov affinity-based graph imputation of cells (MAGIC) (van Dijk et al., 2018) also shows a distinct subpopulation of venous ECs with predominant expression of Icam1 and Irf1 (Figure 2G and Figure 2—figure supplement 3C), excluding the possibility that the heterogeneity of cerebral venous ECs is a computational artifact.

Figure 2 with 3 supplements see all
Download asset Open asset
Endothelial cell (EC) subclustering and identification of intercellular adhesion molecule-1 (ICAM-1+) endothelial population.

(A–B) Uniform manifold approximation and projection (UMAP) plots of 10,741 adult and aged mouse ECs. Colors represent cell subclusters (A) or age groups (B), respectively. Box indicates ICAM-1+ reactive endothelial venule (REV) ECs. (C) UMAP plots depicting the expression of ICAM-1+ EC-enriched genes Vcam1, Icam1, Irf1, and Vwf. Color represents scaled expression level. (D) Dot plot showing the expression of top subcluster-specific genes, with the dot size representing the percentage of cells expressing the gene and colors representing the average expression of the gene within a cluster. (E) Bar plot showing frequency of subclusters for adult and aged ECs. (F) Top gene ontology GO0 biological process terms enriched in REV-specific genes. (G) Three-dimensional Principal component analysis (PCA) plots generated by Markov affinity-based graph imputation of cells. Cells are colored representing the expression of selected subtype marker genes (green: Alkbh5 and Tmsb10 for venous ECs; red: Alpl and Fbln5 for arterial ECs; blue: Icam1 and Vcam1 for REVs). (H) Representative immunofluorescence image for ICAM-1 in adult Cdh5-H2BGFP/tdTomato murine brain cortex. Scale bar, 500 μm. Panels at the bottom show isolated ICAM-1 signal for each area marked in the overview image, representing different cortical areas. Scale bars, 150 μm. (I) Immunostaining showing alpha-smooth muscle actin (αSMA), CD31, and ICAM-1 expression. Panels on the right show ICAM-1 signal for arteriole and venule, respectively. Scale bars, 50 μm.

Figure 2—source data 1

Source data for Figure 2E.

https://cdn.elifesciences.org/articles/57520/elife-57520-fig2-data1-v2.xlsx

Using immunostaining on 100-μm thick brain vibratome sections from transgenic reporter mice expressing nuclear green fluorescent protein (GFP) and membrane Tomato specifically in ECs (Cdh5-H2BGFP/tdTomato) (Jeong et al., 2017), we confirmed that ICAM-1+ REVs are present throughout the cortex of immunologically unchallenged juvenile (Figure 2—figure supplement 3D) and adult mouse brain (Figure 2H). ICAM-1+ vessels in the brain parenchyma are predominantly venules with a diameter ranging from 8 to 50 μm (Figure 2—figure supplement 3E) and low-to-negative coverage by alpha-smooth muscle actin+ (αSMA+) mural cells (Figure 2I), suggesting that they represent a subpopulation of smaller venules, potentially postcapillary venules where leukocyte extravasation into the brain predominantly occurs. While it was not possible to detect VCAM-1 staining in naïve brains, the cellular frequency of Icam1 and Vcam1 double-positive ECs ranges from 1 to 3% of total ECs in all stages analyzed (Figure 2—figure supplement 3F). Postcapillary venules are the main site of leukocyte extravasation, in most tissues and in the brain, are associated with a perivascular space, defined by the inner endothelial and outer parenchyma or astroglial basement membranes, where activated leukocytes accumulate before entry into the brain parenchyma (Sixt et al., 2001; Zhang et al., 2020). To test whether the ICAM-1+ subpopulation is related to leukocyte trafficking upon an acute inflammation, we intraperitoneally injected adult mice with 10 mg/kg of lipopolysaccharides (LPS), perfused the vasculature with ice-cold PBS after 2 hr to remove nonadherent cells from the vessel lumen, and performed immunostaining. Interestingly, this revealed the accumulation of CD3+ lymphocytes at ICAM-1+ venules prior to significant upregulation of ICAM-1 in other endothelium (Figure 2—figure supplement 3G), suggesting that the ICAM-1+ vessel subset might serve as the first entry site of the activated leukocytes to the brain parenchyma in settings of neuroinflammation. Based on these findings, we refer to this vessel compartment as ‘reactive endothelial venules’ (REVs).

PVMs reside in close proximity of ICAM-1 expressing REV ECs

Brain parenchyma-resident myeloid cell types, namely microglia and PVMs, share expression of myeloid surface markers including CD68, Fcgr3 (CD16), Cx3cr1, and Aif1 (Figure 3—figure supplement 1A) and are GFP+ in Cx3cr1 reporter mice (Jung et al., 2000; Figure 3—figure supplement 1B). At the same time, single-cell transcriptome analysis shows molecular differences between the two cell populations (Figure 3A), which also correlate with distinct morphologies and localization (Figure 3—figure supplement 1B, C). As the heterogeneity of microglia during development, ageing, and brain pathogenesis including Alzheimer’s disease, toxic demyelination, and neurodegeneration has been extensively analyzed at the single cell level (Hammond et al., 2019; Keren-Shaul et al., 2017; Masuda et al., 2019), we focused on the characterization of PVMs in this study. CD206 is predominantly expressed by PVMs (Figure 3—figure supplement 1D), and CD206+ PVMs are localized between the subendothelial basement membrane and GFAP+ astrocyte processes (Figure 3B–D). PVMs are clearly distinct from EC-associated pericytes (Figure 3C, asterisks) and Pdgfra-expressing adventitial fibroblast-like cells (Figure 3D). Consistent with previous reports showing that PVMs are associated with both arteries and veins in the CNS (Faraco et al., 2017; Faraco et al., 2016), we found PVMs in the proximity of ICAM-1+ vessels in cortex, thalamus, hippocampus, midbrain, and floor plate (Figure 3E and F).

Figure 3 with 1 supplement see all
Download asset Open asset
Localization of perivascular macrophages (PVMs).

(A) Heatmap and expression dot plot for top differentially expressed genes between microglia and PVMs. Dot size represents the percentage of cells expressing each gene, and color keys indicate scaled expression in each age group. (B) Immunostaining showing CD206+ Cx3cr1-GFP+ PVMs in perivascular space (asterisk) between ECs (CD31) and astrocyte limitans (GFAP). Scale bars, 50 μm (left), 25 μm (right). (C–D) Spatial arrangement of PVMs (CD206), astrocyte limitans (GFAP), pericytes (CD13, asterisks), perivascular fibroblasts (Pdfgra- GFP+), and endothelial cells (ECs; CD31). Scale bars, 25 μm. (E) Confocal image showing Cx3cr1-GFP + microglia and vessel-associated PVMs (arrowheads) next to ICAM1+αSMA- CD31+ REV ECs. Scale bar, 50 μm. (F) CD206+ PVMs are associated with ICAM-1+ REVs in the indicated brain regions. Scale bars, 100 μm.

Subclustering analysis indicated at least two different PVM populations, namely Lyve1+ and MHC class II+ (MHCII+) PVMs (Figure 4A–C), and differential gene expression analysis revealed unique transcriptomic landscapes of the two subtypes (Figure 4D, Figure 4—figure supplement 1A, B). Immunostaining of Lyve1 and MHCII also shows the two subtypes in association with ICAM-1+ vessels (Figure 4E). Interestingly, GSEA for KEGG signalling pathways indicates that Lyve1+ PVMs show enriched expression of genes associated with lysosome activity and endocytosis as well as Wnt signalling, whereas MHCII+ PVMs show enrichment of terms such as antigen processing and presentation, cell adhesion molecules, and Toll-like receptor signalling pathway (Figure 4F, Figure 4—figure supplement 1C). Macrophages can be broadly divided into classical (M1) and alternative (M2) subtypes (Mantovani et al., 2005; Mantovani et al., 2004). M1-polarized macrophages are strongly positive for MHC class II and present antigen to T lymphocytes that neutralize cells with viral or bacterial infections. Macrophages with M2 polarization display homeostatic or anti-inflammatory activity and have a higher endocytic ability compared to M1 macrophages (Tarique et al., 2015). Interestingly, Lyve1+ PVMs express anti-inflammatory or immune-suppressive (M2 macrophage-like) polarization genes, such as Ccr1, Cd163, Cd209a/f, Cd302, Igf1, Il21r, Mrc1, Stab1, Tgfb1, and Tslp, while MHCII+ PVMs show increased levels of proinflammatory (M1-like) genes, Cxcl9, Cxcl10, Cxcl13, Cxcl16, Irf5, Il1a/b, Cxcr4, Il2ra, and Tlr2 (Figure 4G). Both PVM subtypes are found at all stages investigated, but the frequency of MHCII+ PVMs increases with ageing, which correlates with a decrease in the frequency of Lyve1+ PVMs (Figure 4H). Not only the cell population but also the expression levels of MHCII genes are upregulated, whereas Lyve1 or Ccl24 expression is downregulated in aged PVMs (Figure 4I). These results indicate that specific PVM subtypes, characterized by distinct immunological signatures, are associated with ICAM-1+ REVs.

Figure 4 with 1 supplement see all
Download asset Open asset
Perivascular macrophage (PVM) heterogeneity.

(A) Uniform manifold approximation and projection (UMAP) plot of 1725 PVMs from juvenile, adult, and aged mice distributed into Lyve1+ and MHCII+ subclusters. (B) Split UMAP plots of PVMs from juvenile, adult, and aged samples. (C) UMAP plots depicting the expression of Mrc1, Cd68, Lyve1, and H2-Aa. Color represents the scaled expression level. (D) Heatmap of top marker genes for Lyve1+ and MHCII+ PVMs. (E) Immunostaining showing Lyve1+ (red arrows) or MHCII+ PVMs (arrow heads) associated to ICAM-1+ REVs. Scale bar, 50 μm. (F) Representative gene set enrichment analysis plots for overrepresented KEGG pathways in Lyve1+ and MHCII+ PVMs. (G) Dot plot of genes related to M1- or M2-like phenotypes in PVM subtypes. Dot size represents percentage of cells expressing the gene, and colors represent the average expression of each gene. (H) Bar plot showing the frequency of PVM subtypes in different age groups. (I) Ridge plots of Lyve1, Ccl24, and MHCII genes in PVMs at different ages.

Figure 4—source data 1

Source data for Figure 4H.

https://cdn.elifesciences.org/articles/57520/elife-57520-fig4-data1-v2.xlsx

ICAM-1+ ECs are the most reactive EC population in EAE

To extend our analysis of brain ECs and PVMs to neuroinflammatory disease, we analyzed the transcriptome of non-neuronal cell types in the brain cortex during EAE at single-cell resolution. In contrast to age-matched control mice, brain-infiltrating inflammatory cells, activated macrophages, neutrophils, and lymphocytes were significantly enriched in EAE (Figure 5—figure supplement 1A, B). EAE mice show onset of disease symptoms between 9 and 12 days and peak disease severity between 14 and 18 days after immunization with significant reduction of myelin basic protein (MBP) levels in the brain cortex (Figure 5—figure supplement 1C). The comparative analysis of ECs from healthy adults vs. peak EAE indicates the emergence of inflammatory ECs upon neuroinflammation (Figure 5A, Figure 5—figure supplement 2A). These ECs share the molecular features of CapV (Figure 5—figure supplement 2B) but show higher level of genes related to immune responses such as Ctla2, Lcn2, and Mt2 (Figure 5—figure supplement 2C). REV-specific marker genes, Icam1 and Lrg1 are also upregulated in inflammatory ECs (Figure 5B). Consistent with published reports (Dopp et al., 1994), both the area and level of endothelial ICAM-1 expression are increased in EAE (Figure 5C and D). Interestingly, ICAM-1 expression in the brain parenchyma persists in REVs and, in peak EAE, expands into adjacent vessels (Figure 5C, Figure 5—figure supplement 3A).

Figure 5 with 4 supplements see all
Download asset Open asset
Gene expression changes in endothelial cells (ECs) by experimental autoimmune encephalomyelitis (EAE).

(A) Uniform manifold approximation and projection (UMAP) plots of 11,810 ECs from adult and EAE mice. Colors represent each EC subcluster (left) or condition (right). (B) UMAP plots depict Icam1 and Lrg1 expression in ECs from adult and EAE mice. Color represents the scaled expression level. (C) Immunostaining showingαSMA, CD31, and ICAM-1 expression in control and EAE mice. Arterial (A) and venous vessels (V) are indicated. Scale bars, 100 μm. (D) Quantification of ICAM-1+ vessel area and immunohistochemistry signal intensity in the brain cortex of control and EAE mice at disease onset (EAE onset) and peak (EAE peak). Error bars represent mean ± s.e.m. from three animals. (E) Immunofluorescence images showing CD45+ leukocytes near ICAM-1+ REVs in the cerebral cortex of control and EAE mouse. CD31 indicates all ECs. Scale bars, 70 μm.

Figure 5—source data 1

Source data for Figure 5D.

https://cdn.elifesciences.org/articles/57520/elife-57520-fig5-data1-v2.xlsx

It has been reported that high levels of ICAM-1 expression in ECs promote transcellular diapedesis of encephalitogenic T cells and, in absence of endothelial ICAM-1 and ICAM-2 in mutant mice, EAE symptoms were ameliorated (Abadier et al., 2015). Accordingly, upon EAE, leukocytes accumulate at ICAM-1+ REVs and enter the adjacent brain parenchyma (Figure 5E, Figure 5—figure supplement 3B, C).

EAE alters gene expression in REVs (Figure 5—figure supplement 4A, B), including significant upregulation of regulators of blood vessel development, such as Pdgfb and Ctgf, Cd74 antigen (invariant polypeptide of the major histocompatibility complex, class II antigen-associated), the hemostasis regulator Vwf, an interferon gamma-stimulated gene mediating host immune responses (Ch25h), a gene involved in the cellular stress response (Maff), and numerous other genes related to antigen processing and presentation as well as cellular responses to hydrogen peroxide or radiation (Figure 5—figure supplement 4C, D). Collectively, our results indicate that ICAM-1+ postcapillary venules or REVs are molecularly specialized and function as a gateway for the entry of activated leukocytes through the BBB.

PVMs in EAE and cell-to-cell interactome analysis of BBB

The analysis of PVMs in adult and EAE mice indicates that these cells rarely proliferate (Figure 6—figure supplement 1A), and their morphology and localization around ICAM-1+ REVs persist in EAE (Figure 6A and B and Figure 6—figure supplement 1B). Nevertheless, EAE induces profound changes in PVM gene expression. MHCII+ PVM-enriched genes, such as Cxcl16, Ccl8, Cd52, and MHCII genes, are significantly upregulated in most of the PVMs, whereas Lyve1+ PVM-enriched genes, namely Lyve1, Igf1, Cd163, Ccl24, Folr1, and Cd209f, are not changed or decreased (Figure 6D and E). This supports the hypothesis that polarization of macrophages toward inflammatory and non-inflammatory phenotypes is not fixed, and that these cells possess plasticity, integrating diverse inflammatory signals with physiological and pathological functions (Jordão et al., 2019; Murray, 2017). In addition, differential gene expression analysis comparing PVMs and brain parenchyma-infiltrated activated macrophages (Mac) further illustrates the molecular differences between PVMs and circulating peripheral monocytes/macrophages (Figure 6F and G), which may prove relevant for potential therapeutic approaches involving the targeting and modulation of different types of macrophages.

Figure 6 with 1 supplement see all
Download asset Open asset
Experimental autoimmune encephalomyelitis (EAE)-induced changes in perivascular macrophages (PVMs).

(A) Representative immunohistochemistry images for CD206+ PVMs and ICAM-1+ vessels in control and EAE brain cortical parenchyma. Scale bars, 100 μm. (B) Frequency of CD206+ PVMs associated to ICAM-1+ vessels in brain cortical parenchyma of control and EAE mice at disease onset (EAE onset) and peak (EAE peak). (C) Uniform manifold approximation and projection (UMAP) plots of 919 PVMs from adult and EAE mice. (D) UMAP plots depicting the expression of Lyve1, H2-Aa, Ccl8, and Cd52 in PVMs of adult control and EAE mice. Color indicates the scaled expression. (E) Ridge plots of Lyve1+ and MHCII+ PVM marker genes in adult and EAE PVMs. (F) MA plot of differentially expressed genes between PVMs from healthy adult and EAE brain. Blue dots, p-adjusted value  <0.001; red dots, p-adjusted value  <0.001, and Log2 fold change >0.5. (G) Heatmap of selected differentially expressed genes (Padj <0.001) across adult and EAE PVMs and activated macrophages (Mac). Color indicates the scaled average expression.

Figure 6—source data 1

Source data for Figure 6B.

https://cdn.elifesciences.org/articles/57520/elife-57520-fig6-data1-v2.xlsx

We next used CellPhoneDB (Vento-Tormo et al., 2018) to identify potential receptor-ligand complexes mediating cell-to-cell communication between different cell populations at the BBB. First, we analyzed the communication between REVs and adjacent CapV and venous ECs. REVs show expression of various autologous signalling molecules regulating fundamental aspects of EC behavior, including Wnt5a, Tnfsf12, Tgfb1, Jag1, collagens, and immune-regulatory genes with their corresponding receptors (Figure 7A). CapV and venous ECs express higher level of Esam, which encodes EC-selective adhesion molecule, an immunoglobulin-like transmembrane protein associated with endothelial tight junctions. CapV and venous ECs also express the chemokine, and Cxcl12 and REVs express the corresponding receptor Ackr3 encoding CXCR-7, which might enable communication between EC subsets. Potential molecular interactions that upregulated in REVs by EAE include members of the tumor necrosis factor receptor superfamily, TGFβ receptors, integrins, the HLA class II histocompatibility antigen gamma chain CD74, the receptor tyrosine kinase TEK, and the PLXNB2 receptor for semaphorin ligands (Figure 7A and B). These results also suggest that REVs are a major signal distributor among the EC populations in CNS, which is further enhanced by EAE (Figure 7C). We also identify putative signalling interactions between REVs and other cell types in the brain vasculature during homeostasis and neuroinflammation (Figure 7—figure supplement 1). Notably, REVs express growth factors including PDGF-B, CTGF, and TGFβ1, which regulate cellular behavior, tissue remodelling, and angiogenesis. Signalling to other cell types is further enhanced by EAE, which involves the activation of various signals in astroependymal cells. By contrast, expression of PDGF-A, IGF2, and PGF in mural cells and of IGF1, TGFB1, and IGFBP4 in PVMs, for example, was not significantly changed upon EAE (Figure 7D). Our results collectively suggest that postcapillary venules form a specialized vessel compartment in the CNS. We propose that REVs might play roles in the regulation of immune surveillance in the CNS not only under homeostatic conditions but also in pathogenic neuroinflammation.

Figure 7 with 2 supplements see all
Download asset Open asset
Interactions between different endothelial cell (EC) subpopulations and blood-brain barrier (BBB) cell types.

(A) Overview of potential ligand-receptor interactions for CapV, reactive endothelial venule (REV), and venous EC populations in adult and experimental autoimmune encephalomyelitis (EAE) based on gene expression. Circle size indicates p-values. Color key indicates the means of the average expression levels of interacting molecules. (B) Diagram of the main ligand-receptor interactions regulated by EAE. (C) Diagram of the numbers of ligand-receptor interactions on CapV, REV, and venous EC populations in healthy adult and EAE brain. (D) Circos plots for ligand-receptor interactions between REV ECs, mural cells (Mural), perivascular macrophages (PVMs), and astroependymal cells (Astro) in adult and EAE. Each plot shows top 100 highly expressed interactions. The lines and arrow heads are scaled to indicate the relative expression level of the ligand and receptor, respectively.

Discussion

Here, we provide a comprehensive single-cell transcriptomic atlas of non-neural components of the murine brain vasculature during growth, adulthood, ageing, and in EAE. Using this data, we establish the existence of a specialized vessel subtype, which is characterized by a distinct endothelial gene expression profile and presence of ICAMs. In response to pro-inflammatory (LPS) stimulation or in the neuroinflammatory condition of EAE, REVs, but not the far more abundant ICAM-1- vessels, are associated with leukocytes, suggesting that the ICAM-1+ subset of postcapillary venules serves as a first site of immune cell accumulation prior to entry into the brain parenchyma. Such a role of REVs as an interface for innate and adaptive immune cells might be also relevant under homeostatic conditions, when the recruitment of these cells is rare and their activity but also their entry into the brain parenchyma is tightly regulated (Schwartz et al., 2013). The association of MHCII+ and Lyve1+ PVM populations with REVs might mediate immunomodulatory responses, and the predominant gene expression changes in REVs upon immunological challenge highlight further that these vessels might be critical for the immune privileged status of the CNS with potential implications for ageing and neurodegenerative diseases.

Several previous studies on scRNA-seq analysis of murine or human brain have recovered only a limited number of vascular cells due to the comparably high abundance of neural cells (Han et al., 2020; Zeisel et al., 2015). In other publications, fluorescence-activated cell sorting (FACS) or microbead-mediated isolation of ECs as well as of both ECs and mural cells has provided insight into the organ-specific specialization, transcriptional regulation, and arterial-venous zonation of brain vessels in the healthy organism (He et al., 2018; Kalucka et al., 2020; Sabbagh et al., 2018; Vanlandewijck et al., 2018). While sorting based on certain cell surface markers or fluorescent reporters enables the efficient enrichment of the desired cell populations, it has to be considered that these approaches are biased and will miss cells lacking expression of the relevant markers. This limitation is avoided by our demyelination approach, which does not rely on the expression of specific cell surface proteins or fluorescent reporters. Despite of the differences in the experimental approach, data generated by Vanlandewijck et al., 2018 confirms the enriched expression of Icam1 and Vwf in a fraction of venous ECs, which is consistent with our own findings. Transcriptomic changes in brain ECs associated with the aging have been also investigated previously, and it has been proposed that soluble brain EC-derived Vcam1, generated by shedding, activates microglia and impairs the function of hippocampal neural precursors (Chen et al., 2020; Yousef et al., 2019). Our own study confirms that aging increases transcripts associated with inflammation in brain ECs, and, in particular, in REVs. Similarly, EAE results in the upregulation of proinflammatory gene expression in ECs with potential implications for neuroinflammation and disease development.

In the healthy organism, the CNS contains a highly selective barrier system to restrict peripheral immune cell entry into brain parenchyma. During pathophysiological conditions, activated T cells can enter the perivascular space independent of antigen specificity (Kawakami et al., 2005) along postcapillary venules (Raine et al., 1990). However, only after acquiring the ability to move across the glia limitans by recognition of cognate antigen displayed by perivascular APCs, T cells traverse into the parenchyma (Lodygin et al., 2013). Firm attachment of T cells to ECs to resist the vascular shear stress and prolonged crawling before diapedesis is also critical for immune cell extravasation (Steiner et al., 2010). Our findings suggest that functionally specialized REV ECs enable the sustained immune surveillance process alongside the postcapillary venules, serving as the cellular gateway of BBB. In this sense, REVs share some functional features with high endothelial venules in secondary lymphoid organs that support circulating lymphocyte extravasation and physical contact with APCs (Girard and Springer, 1995). Because of the restricted afferent and efferent communication with lymphatic tissue in CNS parenchyma, these specialized postcapillary ECs are probably relevant for fine-tuned CNS immune reactions.

Our work also shows transcriptionally distinguishable subtypes of brain resident PVMs, physically associated with REVs in postcapillary venules, which might serve as APCs for CNS immune surveillance and thereby as gate-keepers at the BBB. It has been reported that PVMs are derived from early yolk-sac-derived erythromyeloid progenitors, similar to microglia and have minimal turnover during homeostasis (Goldmann et al., 2016). The transcriptional continuum between the PVM subtypes and the coherent activation upon EAE reflect the ability of PVMs to swiftly adapt to changing immunological and environmental cues. Nevertheless, PVMs retain distinct molecular characteristics relative to infiltrating peripheral macrophages even though all these cells are exposed to the same perivascular microenvironment. More detailed understanding of the mechanisms that determine the behavior of PVMs and peripheral macrophages upon neuroinflammation will be important, especially for attempts to target specific cell populations and modulate local immune responses. Delivery of drugs or therapeutic cells (e.g. chimeric antigen receptor T cells) across the BBB is a limiting factor in the future development of new therapeutics for the brain diseases, such as Alzheimer’s disease and various brain tumours (Pardridge, 2019).

The sum of our work reveals critical aspects of vascular heterogeneity in the CNS and thereby provides a valuable resource for cell-cell interactions and the molecular modulation of immune cell trafficking into the CNS, with relevance for brain function in health and disease.

Methods

Mice

C57BL/6 female mice were used unless stated otherwise. Cdh5- H2BGFP/tdTomato (Jeong et al., 2017), Cx3cr1-GFP (Jung et al., 2000), and Pdgfra-GFP transgenic mice were used to specifically label EC, Micro + PVM, and Fibro, respectively. All animal experiments were performed in compliance with the relevant laws and institutional guidelines, approved by local animal ethic committees, and conducted with permissions (84–02.04.2016 .A525, 81–02.04.2020 .A471 and 84–02.04.2017 .A322) granted by the Landesamt für Natur, Umwelt und Verbraucherschutz (LANUV) of North Rhine-Westphalia, Germany.

EAE and LPS treatment

EAE was induced as previously described (Gerwien et al., 2016). In brief, 150 μl of 0.75 mg/ml myelin oligodendrocyte glycoprotein 33–55 peptides (MOG35–55) mixed with Complete Freund’s Adjuvant (FS8810; Sigma-Aldrich) was injected subcutaneously into the tail base of 7–11-week-old female C57Bl/6 mice. On the day of immunization and on day 2, 100 μl of 2 μg/ml pertussis toxin (P7208; Sigma-Aldrich) was injected intravenously. Mice were monitored daily for development of disease symptoms. EAE was graded on a 0–5 scale as follows: score 0, no clinical symptoms; score 1, flaccid tail; score 2, hindlimb weakness or partial paralysis; score 3, severe hindlimb weakness or paralysis; score 4, forelimb paralysis; and score 5, paralysis in all limbs or death. Mice typically reached a peak of disease symptoms between days 14 and 18 after immunization, before disease resolution. The disease typically correlates with weight loss; killing of mice was required when weight loss exceeded 20–30% of the initial body weight.

For acute LPS treatment, mice were intraperitoneally injected with a single dose of 10 mg/kg LPS (L2630-25MG; Sigma-Aldrich). Control animals received the same volume of PBS (data not shown). Mice were sacrificed at 2 hr after the injection.

Single-cell RNA-seq library preparation and sequencing

Mice were perfused transcardially with ice-cold PBS under anesthesia. Brains were isolated and dabbed with filter paper for the removal of meninges. After the removal of olfactory bulbs and cerebellum, brain cortex tissues were dissected and digested using the enzyme-cocktail solution of 30 U/ml papain (LK003153; Worthington) and 0.125 mg/ml Liberase TM (5401119001; Sigma-Aldrich) in Dulbecco's Modified Eagle Medium (DMEM, Sigma-Aldrich) for 60 min at 37°C. Homogenized tissues were combined with 1.7-fold volume of 22% BSA in PBS and then centrifuged at 1000× g for 10 min for myelin removal. After washing with ice-cold DMEM, dead cells and debris were removed using ClioCell nanoparticles (Amsbio) according to the manufacturer’s instructions. Single cells were counted using Luna-II automated cell counter (Logos Biosystems) and captured using the 10X Chromium system (10X Genomics). We pooled tissues from three (for aged and EAE samples) or six (for juvenile and adult samples) mice to reduce the effect of sample-dependent individual variations. Libraries were prepared according to the manufacturer’s instructions using Chromium Single Cell 3’ Library & Gel Bead Kit v2 (10X Genomics) and sequenced on the Illumina NextSeq 500 using High Output Kit v2.5 (150 cycles, Illumina) for 26 bp +98 bp paired-end reads with 8 bp single-index aiming raw sequencing depth of >20,000 reads per cell for each sample.

Single-cell RNA-seq data analysis

Sequencing data were processed with UMI tools (Smith et al., 2017) (version 1.0.0), aligned to the mouse reference genome (mm10) with STAR (Dobin et al., 2013) (version 2.7.1 a), and quantified with Subread featureCounts (Liao et al., 2014) (version 1.6.4). Data normalization, detailed analysis, and visualization were performed using Seurat package (Butler et al., 2018) (version 3.1.5). For initial quality control of the extracted gene-cell matrices, we filtered cells with parameters nFeature_RNA >500 & nFeature_RNA <6000 for number of genes per cell and percent.mito <25 for percentage of mitochondrial genes and genes with parameter min.cell=3. Filtered matrices were normalized by LogNormalize method with scale factor = 10,000. Variable genes were found by FindVariableFeatures function with parameters of selection.method = ‘vst’, nfeatures = 2000, trimmed for the genes related to cell cycle (GO:0007049) and then used for principal component analysis. FindIntegrationAnchors and IntegrateData with default options were used for the data integration. Statistically significant principal components were determined by JackStraw method, and the first 12 principal components were used for UMAP nonlinear dimensional reduction. Unsupervised hierarchical clustering analysis was performed using FindClusters function in Seurat package. We tested different resolutions between 0.1 and 0.9 and selected the final resolution using clustree R package to decide the most stable as well as the most relevant for our previous knowledges. Cellular identity of each cluster was determined by finding cluster-specific marker genes using FindAllMarkers function with minimum fraction of cells expressing the gene over 25% (min.pct=0.25), comparing those markers to known cell type-specific genes from previous studies.

Data were further trimmed for clusters of multiplets, low-quality cells (mitochondrial gene-enriched), contaminated neurons (Tubb3+), oligodendrocytes (Mbp+), lymphocytes (Igkc+ or Nkg7+), red blood cells (Hba−a1+), and ependymal cells (Tmem212+) and then reanalyzed. For subclustering analysis, we isolated specific cluster(s) using subset function, extracted data matrix from the Seurat objectusing GetAssayData function, and repeated the whole analysis pipeline from data normalization.

Differentially expressed genes were identified using the nonparametric Wilcoxon rank sum test by FindMarkers function of Seurat package. We used default options for the analysis if not specified otherwise. Results were visualized using EnhancedVolcanoR package (version 1.10.0). FeaturePlot, VlnPlot, and DotPlot functions of Seurat package were used for visualization of selected genes. The ‘VlnPlot’ function of Seurat package was used for violin plots to show the expression level of selected genes with log normalized value by default.

Monocle (Trapnell et al., 2014) (version 2.12.0) was used for pseudotime trajectory analysis. We imported Seurat objects to Monocle R package and then performed dimensionality reduction with DDRTree method with parameters max_components = 2 and norm_method=‘log’. Cell cycle phases were classified by cyclone function of scran (Lun et al., 2016) (version 1.14.5). We also used MAGIC (van Dijk et al., 2018) (version 1.4.0.9000) for an alternative dimensionality reduction and CellPhoneDB (Vento-Tormo et al., 2018) for ligand-receptor interactome analysis. An R package iTALK (https://doi.org/10.1101/507871) was used for the ligand-receptor interactome analysis. For the analysis of each single sample, top 50% of genes in their mean expression values were selected and used for ligand-receptor pair identification using FindLR function with datatype = mean count. All the analysis scripts are available from vignettes of original software webpage of Seurat, Monocle, MAGIC, CellPhoneDB, or iTALK. No custom code or mathematical algorithm other than variable assignment was used in this study.

Flow cytometry

Brain cortex tissues from transcardially perfused P10 Cdh5- H2BGFP/tdTomato transgenic mice were dissected and treated by different digestion conditions, namely papain solution, papain + liberase cocktail solution, or papain + liberase cocktail solution followed by myelin removal. EC-specific H2BGFP and tdTomato fluorescences were directly analyzed after single/live cell gating in forward scattered/side scattered plot using FACSVerse flow cytometer (BD). For brain-infiltrated leukocyte analysis, brains from transcardially perfused mice were dissected and crushed with FACS buffer (2% FCS, 2 mM EDTA in DPBS) using 100 um mesh and plunger. After collecting the cell suspension with 10 ml of FACS buffer, centrifugation was performed to make cell pellet. Percoll gradient was performed, and a layer that contains mononuclear cells was collected for further FACS analysis. 105 cells were stained with fluorescence conjugated antibodies, CD45-APC-Cy7 (BD 557659) and CD3e-FITC (Thermo 11–0031) for 30 min at 4°C. The analysis is performed with BD FACSymphony A3 Cell Analyzer. FlowJo software (version 10.5.3, FlowJo, LLC) was used for further analysis.

Immunohistochemistry

Mice were perfused transcardially with ice-cold PBS and subsequently with 2% paraformaldehyde (PFA) under anesthesia. Whole brain tissues were dissected and further fixed with 4% PFA or 100% methanol at 4°C for overnight. Methanol-fixed samples were rehydrated by serial incubation (15–20 min each, at RT) in increasing concentrations of PBS:methanol solution (25, 50, 75, and 100% PBS). The fixed brains were glued to a mounting block with cyanoacrylate glue (48700; UHU), submerged in ice-cold PBS, and sliced with 100-µm thickness using vibrating blade microtome (VT1200, Leica). Sections were blocked and permeablilized by 1% BSA and 0.5% Triton X-100 in PBS for overnight. Incubation with blocking/permeabilization solution containing primary antibodies at 4°C for overnight was followed by secondary antibody staining using suitable species-specific Alexa Fluor-coupled antibodies (Invitrogen) and flat-mounting in microscope glass slides with Fluoromount-G (0100–01; SouthernBiotech). The following primary antibodies were used for immunostaining: rabbit anti-ICAM-1 (Abcam ab222736, 1:100), rat anti-ICAM-1 (BioLegend 116102, 1:100), mouse anti-αSMA-Cy3 (Sigma C6198, 1:300), mouse anti-αSMA-660 (eBioscience 50-9760-82, 1:300), chicken anti-GFP (2BScientific Ltd. GFP-1010, 1:300), goat anti CD31 (R&D Systems AF3628, 1:200), rabbit anti-CD206 (Abcam ab64693, 1:100), rat anti-CD206 (BioRad MCA2235T, 1:100), rabbit anti-GFAP (DAO Z0334, 1:200), rat anti-CD13 (AbD Serotec MCA2183GA, 1:100), hamster anti-CD3e-FITC (eBiosciences 11–0031, 1:100), rabbit anti ColIV (AbD Serotec 2150–1470, 1:100), rat anti-CD68 (Abcam ab53444, 1:200), goat anti-Olig2 (R&D Systems AF2418, 1:100), rabbit anti-MHC Class II (Abcam ab180779, 1:100), rat anti-CD45 (Becton Dickinson 550539, 1:200), and rat anti MBP (Abcam ab7349, 1:200). The following donkey-raised secondary antibodies (all in 1:400 dilution unless otherwise stated) were used for immunostaining: anti-rabbit IgG conjugated to Alexa Fluor (AF) 488 (Thermo Fisher Scientific A21206), anti-chicken IgY AF488 (Jackson ImmunoResearch 703-545-155), anti-goat IgG AF488 (Invitrogen, A-11055), anti-rat IgG Cy3 (Jackson ImmunoResearch 712-165-153), anti-rabbit IgG AF546 (Thermo Fisher Scientific A10040), anti-rat IgG AF594 (Thermo Fisher A21209), anti-rabbit IgG AF594 (Thermo Fisher Scientific A21207), anti-rabbit IgG AF647 (Thermo Fisher Scientific A31573), and anti-goat IgG AF647 (Thermo Fisher Scientific A21447). Streptavidin AF405 (Invitrogen S32351, 1:200) was used for detection of biotinylated-IB4 stained samples. Nuclei were counterstained with 4’,6-diamidino-2-phenylindole (Sigma, D9542) diluted at 1 μg ml–1 together with the secondary antibodies.

Statistics and reproducibility

No statistical methods were used to predetermine sample size. The experiments were not randomized, and investigators were not blinded to allocate during experiments and outcome assessment.

Data sets with normal distributions were analysed with unpaired Student’s two-tailed t-tests to compare two conditions. Results are depicted as mean  ± s.e.m. as indicated in figure legends. All experiments for quantitative analysis and representative images were reproduced at least three times.

Data availability

Raw data (fastq files) and processed data (gene counts) for single cell RNA-Seq analysis have been deposited in the Gene Expression Omnibus with the primary accession number, GSE133283.

The following data sets were generated
    1. Jeong H
    2. Adams RH
    (2019) NCBI Gene Expression Omnibus
    ID GSE133283. Single cell transcriptome analysis of non-neuronal cell populations in mouse brain cortex.
    https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE133283

References

    1. Raine CS
    2. Cannella B
    3. Duijvestijn AM
    4. Cross AH
    (1990)
    Homing to central nervous system vasculature by antigen-specific lymphocytes. II. lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination
    Laboratory Investigation; a Journal of Technical Methods and Pathology 63:476–489.

Decision letter

  1. Victoria L Bautch
    Reviewing Editor; University of North Carolina, Chapel Hill, United States
  2. Carla V Rothlin
    Senior Editor; Yale University, United States

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Decision letter after peer review:

Thank you for submitting your article "Single cell transcriptomics reveals functionally specialized vascular endothelium in brain" for consideration by eLife. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Carla Rothlin as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The editors have judged that your manuscript is of interest, but as described below extensive revision is required before it is published. We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is "in revision at eLife". Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)

Summary:

Jeong et al. employ single cell transcriptional profiling to address cellular heterogeneity of the neurovascular unit. By using the murine cerebral cortex as the anatomical site of interest, the authors dissect cellular heterogeneity within four distinct conditions: aging, inflammation, development and adulthood. This approach has revealed a potential new endothelial subset – reactive endothelial venules, which are post-capillary endothelial cells with specialized functions particularly for immune cell transmigration and potential communication with perivascular macrophages within the brain parenchyma.

This study provides insight into largely understudied cell types in the neurovascular unit. Further, it provides for some interesting areas of future investigations into neuroimmune mechanisms that are used by the brain vasculature to control leukocyte transmigration in various health and disease conditions. However, as presented the work is not well-described or annotated, some methodology is not clear, numerous functional claims that are not supported by the data, and relevant work of other labs is not acknowledged and incorporated into the interpretations. The suggestion is to reformat the work as a resource paper with appropriate attributions of work of others, remove extensive unsubstantiated claims, and significantly improve description of the methodology and description of the data.

Essential revisions:

1. What is the gap in knowledge that is filled by this work? The scope of the study is on PVECs and a more suitable introduction with relevant literature citation and gap of knowledge should be included. The current broad claim of "BBB heterogeneity" is not very relevant to the current experimental design and findings in this manuscript. The authors should introduce REVs early on as it is a main finding. Although this cell population is in early data (Figure 2A) the first description and discussion of this cell population is towards the end of the main text.

2. There are many areas of bold claims about probable functional roles without functional data to support these ideas. It is suggested to remove these claims and reformat as a resource paper, with appropriate attribution of other work in the field and comparison of analyses. Specifically: (a) the presented work is done using mice, while recently the human cell atlas was published (PMID: 32214235) that should be re-analyzed to find REVs and address relevance of the mouse model for studies of human disorders; (b) work would benefit from comparison of authors' dataset with previously published data, e.g. of Sabbagh MF et al., 2018 (PMID: 30188322), Vanlandewijck M et al., 2018 (PMID:29925939), He L et al., 2018 (PMID:30129931) or Kalucka J et al. 2020 (PMID: 32059779) to examine reproducibility of gene expression, transcriptomic signatures, and EC subtypes for relevant conditions; (c) recently Tony Wyss-Coray and colleagues reported that brain capillary, arterial, and venous cells age differently at the transcriptome level, that aged capillaries upregulate innate immunity and oxidative stress pathways, and that hippocampal neural precursor activity is impaired via endothelial VCAM1 (PMID: 32234477, PMID: 31086348). These results should be discussed and adequately compared to the newly obtained results. Also, there is speculation and claims about a functional module that may exist between ICAM1+ vessels and PVMs, with little molecular detail in terms of validation or functional data to support this hypothesis. Simply having cell types in the same region does not dictate that they communicate in meaningful ways, so this claim should be removed. The model suggests that perhaps LYVE1+ PVMs may actively suppress leukocytes that enter through REVs but there is nothing to support this, so this claim should be removed.

3. Readability is very low, with extensive lack of concordance between text and data, precluding rigorous assessment. The authors submitted 4 main figures and 9 extended data figures, but refer to 7 main figures and 10 (or 11 based on the figure legend numbering) extended data figures. Some of the figures are missing and panels in figures do not match text (and the other way round). Legends poorly describe the panels. Abbreviations in Figures are not explained. Some figures are overcrowded and presented data is not explained in the main text (e.g. for Figure 1d). Authors should provide rationale behind prioritising the data presented in the main figures. There are several mistakes in the figures themselves. For example, in Figure 1a panels are said to represent UMAP, but t-SNE plots are shown.

4. Some provided images do not support validation claims, e.g. Extended Data Figure 8 does not support statement that ICAM-1 expression in the brain parenchyma remains restricted to veins/venules and slightly expands into adjacent vessels. Double or triple staining to clearly illustrate veins/venules vs. arteries is needed to support these assumptions. Also, based on provided representative images in Extended Data Figure 7c, loss of MBP protein is more severe during the onset of EAE and not in its peak as authors describe in the text. How can the authors explain that? It is also unclear why the authors used Olig2 staining for these experiments.

5. Methodology is not clear. Seq analysis cell numbers are a concern – it is unclear how many cells were obtained in each subpopulations. Methods must include more technical detail. For example, in Figure 2, ~11,000 endothelial cells are analyzed from both adult and aged mice – it is unclear why these two groups are pooled. Tony Wyss-Coray recently reported via seq that brain ECs are transcriptionally different from aged mice, so this could argue that pooling adult and aged ECs into the same analysis is a potential confound. Further, it is unclear how many cells make up ICAM1+ and other subpopulations (I,e, what are the cell numbers of ICAM1+ PVECs and ICAM1-PVECs?). Limited cell counts from the brain vasculature is a known technical issue for sequencing, so cell numbers are important to understand whether methods are appropriate. Are there thousands, hundreds or dozens of ICAM1+ ECs from this overall population? Also, pooling of 3 PVM groups seems likely to lead to possible confounding factors. Why are these 3 groups chosen? The analysis actually indicates that these populations are likely unique (or at least somewhat different) across these conditions, so pooling may not be appropriate. Is there a biological response for this pooling? If cell numbers needed to be increased, would it be more appropriate to increase the number of mice per condition and keep them separate?

[Editors' note: further revisions were suggested prior to acceptance, as described below.]

Thank you for resubmitting your work entitled "Single cell transcriptomics reveals functionally specialized vascular endothelium in brain" for further consideration by eLife. Your revised article has been evaluated by Carla Rothlin (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:

1. Addition of several control panels (Figure 2, Supp 3G; Figure 5E-F).

2. Further proof of T-cell accumulation into the brain under stimulated conditions (see Rev 2 comment below) via images and quantification, and/or careful use of words to exactly describe what is demonstrated by the data in several places.

3. Correction of typos.

For your convenience, the remarks from reviewers are appended below in their entirety.

Reviewer #1 (Recommendations for the authors):

The reviewer would like to thank the authors for considering the submitted remarks. The current version of the manuscript was an absolute pleasure to read. Although the manuscript is not perfect, for example, the authors could try to validate the results obtained from the ligand-receptor analysis or there are still unfinished sentences/typos, e.g. in lines #348 or #352, I do not have any major criticisms that will improve the paper if answered, only some that will delay publication.

I am confident that this study will lay the foundations for future work and will be an excellent resource for the broader scientific community.

Reviewer #2 (Recommendations for the authors):

In this revision, Jeong et al. have dramatically enhanced the rigor of this study and have addressed most of our major concerns originally brought forward. Notably, the overarching, unsubstantiated claims in the first version have been removed or have had significant data additions to help support these claims. Thank you for the addition of the discussion of how your scRNA-seq dataset compares to previously published datasets. Overall, the text is much more readable and the data progression is logical and clear. Prior to publication, there is still one major concern that needs to be addressed and we bring a few minor corrections below.

1. Figure 2, figure supplement 3G – the text in lines 161-162 claims that CD3+ T cells accumulate and penetrate the brain but the images do not clearly demonstrate this. Rather, it appears that they are accumulating, and perhaps not penetrating. This is a really important point to clarify – whether T cells are physically entering the brain at these sites needs to be explored. Better images showing the T cells in the brain parenchyma and/or quantification of the numbers of T cells accumulating and penetrating is warranted. It is also important to note there isn't a control here – there should be a negative (PBS) control to show that T cells in the LPS condition are actually different. EM would be able to prove these cells are transmigrating and/or flow cytometry quantification of T cell numbers in the brain parenchyma could be helpful.

Line 295 in the discussion states "recruitment", but again there is no direct evidence that REVs are actually allowing T cells to recruit to the brain. Even though these sites are likely to be hotspots of leukocyte accumulation, be cautious about using recruitment.

2. Similar to the comments above, for Figures 5 E and F, the authors should show the negative control side-by-side so the reader can really appreciate the differences.

3. In your response to reviewer comments: "LPS treatment promotes the adhesion of CD3+ cells to ICAM-1+ REVs (Figure 2-supplement 3G). While our findings indeed indicate that REVs are present in the absence of any challenge, leukocyte adhesion is extremely rare under baseline conditions. Thus, while we propose that REVs are poised for leukocyte transmigration, this is prevented by the BBB properties of the brain vasculature in the absence of inflammatory challenge."

Are you suggesting that LPS induces loss of BBB features and that controls the difference between the baseline activity of REVs and LPS-induced activity? If so, then presumably REVs are indeed able to allow for attachment of T cells in homeostatic conditions, but only under inflammatory conditions when the BBB is weakened, can recruitment actually occur? Some level of discussion on this topic could be helpful in the discussion.

https://doi.org/10.7554/eLife.57520.sa1

Author response

Summary:

Jeong et al. employ single cell transcriptional profiling to address cellular heterogeneity of the neurovascular unit. By using the murine cerebral cortex as the anatomical site of interest, the authors dissect cellular heterogeneity within four distinct conditions: aging, inflammation, development and adulthood. This approach has revealed a potential new endothelial subset – reactive endothelial venules, which are post-capillary endothelial cells with specialized functions particularly for immune cell transmigration and potential communication with perivascular macrophages within the brain parenchyma.

This study provides insight into largely understudied cell types in the neurovascular unit. Further, it provides for some interesting areas of future investigations into neuroimmune mechanisms that are used by the brain vasculature to control leukocyte transmigration in various health and disease conditions. However, as presented the work is not well-described or annotated, some methodology is not clear, numerous functional claims that are not supported by the data, and relevant work of other labs is not acknowledged and incorporated into the interpretations. The suggestion is to reformat the work as a resource paper with appropriate attributions of work of others, remove extensive unsubstantiated claims, and significantly improve description of the methodology and description of the data.

We are grateful for this assessment of our work. As suggested by the reviewers, we have improved our manuscript and now present our work as a resource paper. As part of our revision, we have included additional references to published work and we have carefully reviewed all claims and conclusions.

Essential revisions:

1. What is the gap in knowledge that is filled by this work? The scope of the study is on PVECs and a more suitable introduction with relevant literature citation and gap of knowledge should be included. The current broad claim of "BBB heterogeneity" is not very relevant to the current experimental design and findings in this manuscript.

We now provide a clear focus on reactive endothelial venules (REVs) as a specialized vessel subtype in the brain vasculature with relevance for neuroinflammation. In the revised manuscript, we have added a paragraph describing the relevance of postcapillary venules and the surrounding perivascular space in CNS immune responses to the Introduction. Furthermore, we now provide a better description of the properties of REVs (see also next question) and avoided “broad” claims about the BBB, which has not been a major subject of the current study.

The authors should introduce REVs early on as it is a main finding. Although this cell population is in early data (Figure 2A) the first description and discussion of this cell population is towards the end of the main text.

We now mention REVs at the end of the Introduction and, as suggested by the reviewer, describe this EC subpopulation in Figure 2.

2. There are many areas of bold claims about probable functional roles without functional data to support these ideas. It is suggested to remove these claims and reformat as a resource paper, with appropriate attribution of other work in the field and comparison of analyses. Specifically: (a) the presented work is done using mice, while recently the human cell atlas was published (PMID: 32214235) that should be re-analyzed to find REVs and address relevance of the mouse model for studies of human disorders;

We have added a paragraph to the Discussion in the revised manuscript and now discuss various previous studies in the context of our work. It has to be noted that many of the previous scRNA-seq studies for brain provide a rather limited coverage of ECs, reflecting the high abundance of neural cells, or have used positive selection (cell sorting) for the isolation of vascular cells. The latter will introduce a certain experimental bias, due to the expression of transgenic reporters, and will obviously miss cells lacking reporter expression.

The data generated by Han et al. (PMID: 32214235) and Human Cell Landscape database (http://bis.zju.edu.cn/HCL) is very useful, but contains only 74 vascular cells (ECs + pericytes) among the 8,531 adult brain cells (see Author response image 1). Therefore, sequential subclustering analysis identifying EC subsets including REV is not feasible with this data.

Author response image 1
Download asset Open asset

(b) work would benefit from comparison of authors' dataset with previously published data, e.g. of Sabbagh MF et al., 2018 (PMID: 30188322),

P7 brain EC heterogeneity/subclustering results reported by Sabbagh et al. (PMID: 30188322) are highly consistent with our P10 EC subclustering results (Figure 2—figure supplement 1). However, Sabbagh et al. did not address EC heterogeneity in adult or aged stages.

Vanlandewijck M et al., 2018 (PMID:29925939), He L et al., 2018 (PMID:30129931)

ECs in these studies were isolated by sorting based on GFP expression in Cldn5-GFP transgenic reporter mice, followed by sequencing using the SmartSeq2 method. However, these ECs are not clearly segregated into different subpopulations by unsupervised hierarchical clustering (e.g. K-nearest neighbor (KNN) graph-based clustering approach). Instead, authors ordered cells into one-dimensional range using the SPIN method based on known arteriovenous markers, which excludes the identification of minor subpopulations. Nevertheless, Icam1 and Vwf are enriched in a fraction of venous ECs (see Author response image 2), which is consistent with our own findings.

Author response image 2
Download asset Open asset

or Kalucka J et al. 2020 (PMID: 32059779) to examine reproducibility of gene expression, transcriptomic signatures, and EC subtypes for relevant conditions;

In addition to traditional EC phenotypes of venous to artery, Kalucka et al. (PMID: 32059779) identified an ‘interferon-activated EC population” in brain (6%), but this population is not consistent with REV. For example, Vwf is not detected in this population, which is, instead, enriched in clusters of large arteries and large veins.

(c) recently Tony Wyss-Coray and colleagues reported that brain capillary, arterial, and venous cells age differently at the transcriptome level, that aged capillaries upregulate innate immunity and oxidative stress pathways, and that hippocampal neural precursor activity is impaired via endothelial VCAM1 (PMID: 32234477, PMID: 31086348). These results should be discussed and adequately compared to the newly obtained results.

Agree. We now discuss these previously published data in the context of our own work. While this was not a main focus of our study, we confirm the expression of pro-inflammatory genes in aged ECs similar to what has been reported by Chen et al. (PMID: 32234477).

Also, there is speculation and claims about a functional module that may exist between ICAM1+ vessels and PVMs, with little molecular detail in terms of validation or functional data to support this hypothesis. Simply having cell types in the same region does not dictate that they communicate in meaningful ways, so this claim should be removed. The model suggests that perhaps LYVE1+ PVMs may actively suppress leukocytes that enter through REVs but there is nothing to support this, so this claim should be removed.

In the revised manuscript, we present our findings such as the association of PVMs with ICAM1+ vessels and the differences between PVM subpopulations without speculating about potential functional consequences. We state, for example, that “Lyve1+ PVMs express anti-inflammatory or immune-suppressive (M2 macrophage-like) polarization genes” without claiming that these cells may actively suppress leukocytes.

3. Readability is very low, with extensive lack of concordance between text and data, precluding rigorous assessment. The authors submitted 4 main figures and 9 extended data figures, but refer to 7 main figures and 10 (or 11 based on the figure legend numbering) extended data figures. Some of the figures are missing and panels in figures do not match text (and the other way round). Legends poorly describe the panels. Abbreviations in Figures are not explained. Some figures are overcrowded and presented data is not explained in the main text (e.g. for Figure 1d). Authors should provide rationale behind prioritising the data presented in the main figures. There are several mistakes in the figures themselves. For example, in Figure 1a panels are said to represent UMAP, but t-SNE plots are shown.

We apologize for any inconsistencies in the original submission. As part of our revision, we have carefully checked the manuscript to ensure that text, figures and legends match each other.

4. Some provided images do not support validation claims, e.g. Extended Data Figure 8 does not support statement that ICAM-1 expression in the brain parenchyma remains restricted to veins/venules and slightly expands into adjacent vessels. Double or triple staining to clearly illustrate veins/venules vs. arteries is needed to support these assumptions.

We have added immunostaining data showing αSMA, ICAM-1 and CD31 (Figure 5C), which confirms venous-restricted ICAM-1 expression.

Also, based on provided representative images in Extended Data Figure 7c, loss of MBP protein is more severe during the onset of EAE and not in its peak as authors describe in the text. How can the authors explain that? It is also unclear why the authors used Olig2 staining for these experiments.

Disease onset or peak of disease are determined based on symptoms displayed by the mice in the experiment. These symptoms are preceded by pathogenic changes in cellular or molecular level (e.g. loss of myelin (MBP) or apoptosis of oligodendrocytes). EAE is a transient model, which, depending on the severity of symptoms, either results in the death or the full or partial recovery of the affected animals (remission) (PMID: 18432984; PMID: 24362236; PMID: 21371012).

Immunization against myelin oligodendrocyte glycoprotein (MOG) is typically used for the induction of EAE and oligodendrocyte death is a feature of both multiple sclerosis and EAE.

Olig2 was used as a marker of oligodendrocytes.

5. Methodology is not clear. Seq analysis cell numbers are a concern – it is unclear how many cells were obtained in each subpopulations. Methods must include more technical detail. For example, in Figure 2, ~11,000 endothelial cells are analyzed from both adult and aged mice – it is unclear why these two groups are pooled. Tony Wyss-Coray recently reported via seq that brain ECs are transcriptionally different from aged mice, so this could argue that pooling adult and aged ECs into the same analysis is a potential confound. Further, it is unclear how many cells make up ICAM1+ and other subpopulations (I,e, what are the cell numbers of ICAM1+ PVECs and ICAM1-PVECs?). Limited cell counts from the brain vasculature is a known technical issue for sequencing, so cell numbers are important to understand whether methods are appropriate. Are there thousands, hundreds or dozens of ICAM1+ ECs from this overall population?

We have added information about cell numbers and subcluster proportions in each plot. Integration of different datasets was necessary for the identification of conserved populations and to investigate further detailed analysis including the DEG test at subcluster resolution.

It is unclear how many postcapillary venules are ICAM1+ REVs, because scRNA-seq does not necessarily provide an accurate readout about cell numbers. Certain cells might more easily recovered than others during the procedure and, conversely, certain cells might be more easily damaged or lost.

Nevertheless, we assume that not all postcapillary venules are REVs because REV ECs with clear molecular characteristics represent only 3% (~400 cells) in our scRNA-seq data. ICAM1-negative non-REV postcapillary venules are not distinguishable from CapV-Venous EC continuum and may not represent a distinct subpopulation.

Also, pooling of 3 PVM groups seems likely to lead to possible confounding factors. Why are these 3 groups chosen? The analysis actually indicates that these populations are likely unique (or at least somewhat different) across these conditions, so pooling may not be appropriate. Is there a biological response for this pooling? If cell numbers needed to be increased, would it be more appropriate to increase the number of mice per condition and keep them separate?

Cell isolation, library preparation and sequencing were done independently for each sample set and the resulting data sets were subsequently integrated to facilitate the identification of differences and common features. Data integration is very informative for subcluster identification and direct comparison of cells from different age or treatment groups.

[Editors' note: further revisions were suggested prior to acceptance, as described below.]

Thank you for resubmitting your work entitled "Single cell transcriptomics reveals functionally specialized vascular endothelium in brain" for further consideration by eLife. Your revised article has been evaluated by Carla Rothlin (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:

1. Addition of several control panels (Figure 2, Supp 3G; Figure 5E-F).

Following your feedback, we have added negative control panels to Figure2—figure supplement 3G as well as in Figure 5E. Control panels have been also added to Figure 5F, which has been repositioned to Figure 5—figure supplement 3B.

2. Further proof of T-cell accumulation into the brain under stimulated conditions (see Rev 2 comment below) via images and quantification, and/or careful use of words to exactly describe what is demonstrated by the data in several places.

As suggested, we have revised our description of events relating to leukocyte trafficking. In particular, we replaced the term “recruitment” with “accumulation” in the discussion panel. In our description of Figure 2—figure supplement 3G, we replaced the term “leukocyte infiltration” with “leukocyte trafficking” and removed the word “penetration”.

In addition, we performed flow cytometry to quantify the brain-infiltrated leukocytes in the EAE model. After removal of circulating cells by robust perfusion, we collected mononuclear cells using a Percoll gradient from the crushed brain tissues without enzymatic dissociation. This showed a striking increase in CD45+ leukocytes at EAE onset and peak. The new data is shown in Figure 5—figure supplement 3C.

Reviewer #1 (Recommendations for the authors):

The reviewer would like to thank the authors for considering the submitted remarks. The current version of the manuscript was an absolute pleasure to read. Although the manuscript is not perfect, for example, the authors could try to validate the results obtained from the ligand-receptor analysis or there are still unfinished sentences/typos, e.g. in lines #348 or #352, I do not have any major criticisms that will improve the paper if answered, only some that will delay publication.

I am confident that this study will lay the foundations for future work and will be an excellent resource for the broader scientific community.

We are grateful to the reviewer for the constructive input and positive evaluation. Of course, our study is not perfect but it is an intrinsic feature of scientific publications that there always limitations and open questions.

Reviewer #2 (Recommendations for the authors):

In this revision, Jeong et al. have dramatically enhanced the rigor of this study and have addressed most of our major concerns originally brought forward. Notably, the overarching, unsubstantiated claims in the first version have been removed or have had significant data additions to help support these claims. Thank you for the addition of the discussion of how your scRNA-seq dataset compares to previously published datasets. Overall, the text is much more readable and the data progression is logical and clear. Prior to publication, there is still one major concern that needs to be addressed and we bring a few minor corrections below.

We are very grateful for this assessment and have used the feedback to improve the manuscript further.

1. Figure 2, figure supplement 3G – the text in lines 161-162 claims that CD3+ T cells accumulate and penetrate the brain but the images do not clearly demonstrate this. Rather, it appears that they are accumulating, and perhaps not penetrating. This is a really important point to clarify – whether T cells are physically entering the brain at these sites needs to be explored. Better images showing the T cells in the brain parenchyma and/or quantification of the numbers of T cells accumulating and penetrating is warranted. It is also important to note there isn't a control here – there should be a negative (PBS) control to show that T cells in the LPS condition are actually different. EM would be able to prove these cells are transmigrating and/or flow cytometry quantification of T cell numbers in the brain parenchyma could be helpful.

Line 295 in the discussion states "recruitment", but again there is no direct evidence that REVs are actually allowing T cells to recruit to the brain. Even though these sites are likely to be hotspots of leukocyte accumulation, be cautious about using recruitment.

As suggested, we have revised our description of events relating to leukocyte trafficking. In particular, we replaced the term “recruitment” with “accumulation” in the discussion panel. In our description of Figure 2—figure supplement 3G, we replaced the term “leukocyte infiltration” with “leukocyte trafficking” and removed the word “penetration”.

In addition, we performed flow cytometry to quantify the brain-infiltrated leukocytes in the EAE model. After removal of circulating cells by robust perfusion, we collected mononuclear cells using a Percoll gradient from the crushed brain tissues without enzymatic dissociation. This showed a striking increase in CD45+ leukocytes at EAE onset and peak. The new data is shown in Figure 5—figure supplement 3C.

2. Similar to the comments above, for Figures 5 E and F, the authors should show the negative control side-by-side so the reader can really appreciate the differences.

As suggested, we have added negative control panels to Figure 2—figure supplement 3G as well as in Figure 5E. Control panels have been also added to Figure 5F, which has been repositioned to Figure 5—figure supplement 3B.

3. In your response to reviewer comments: "LPS treatment promotes the adhesion of CD3+ cells to ICAM-1+ REVs (Figure 2-supplement 3G). While our findings indeed indicate that REVs are present in the absence of any challenge, leukocyte adhesion is extremely rare under baseline conditions. Thus, while we propose that REVs are poised for leukocyte transmigration, this is prevented by the BBB properties of the brain vasculature in the absence of inflammatory challenge."

Are you suggesting that LPS induces loss of BBB features and that controls the difference between the baseline activity of REVs and LPS-induced activity? If so, then presumably REVs are indeed able to allow for attachment of T cells in homeostatic conditions, but only under inflammatory conditions when the BBB is weakened, can recruitment actually occur? Some level of discussion on this topic could be helpful in the discussion.

We propose that REVs facilitate the transmigration of activated leukocyte during neuroinflammation and are already primed for this role under homeostatic conditions without immune cell activation. In the healthy (unchallenged) brain, the adhesion and accumulation of leukocytes in REVs are extremely rare events because immune cells are not activated and LFA-1, a receptor for ICAM-1 expressed on leukocytes, has a low affinity for ICAM-1. However, reports in the literature support that “innate and adaptive immune cells are…known to have protective/healing properties in the CNS, as long as their activity is regulated, and their recruitment is well controlled” (quote taken from a review by Schwartz et al., PMID: 24198349). It therefore seems possible that REVs are able to mediate the attachment of T cells to the brain vasculature in homeostatic conditions and might even control the rare entry of these cells into the brain parenchyma. Immune cell accumulation is greatly enhanced under inflammatory conditions when the BBB is weakened. The expansion of REVs might contribute to this accumulation together with other factors such as the release of chemokines and the activation of immune cells.

We have added a statement to the Discussion on page 12 of the manuscript.

https://doi.org/10.7554/eLife.57520.sa2

Article and author information

Author details

  1. Hyun-Woo Jeong

    Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, Münster, Germany
    Contribution
    Conceptualization, Formal analysis, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing
    For correspondence
    hyun-woo.jeong@mpi-muenster.mpg.de
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6976-6739

  2. Rodrigo Diéguez-Hurtado

    Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, Münster, Germany
    Contribution
    Investigation, Methodology, Writing - review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2055-599X

  3. Hendrik Arf

    Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, Münster, Germany
    Contribution
    Methodology
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2038-705X

  4. Jian Song

    1. Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany
    2. Cells-in-Motion Interfaculty Centre (CiMIC), University of Münster, Münster, Germany
    Contribution
    Formal analysis, Investigation, Methodology
    Competing interests
    No competing interests declared

  5. Hongryeol Park

    Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, Münster, Germany
    Contribution
    Investigation, Methodology
    Competing interests
    No competing interests declared

  6. Kai Kruse

    Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, Münster, Germany
    Contribution
    Formal analysis, Validation, Methodology
    Competing interests
    No competing interests declared

  7. Lydia Sorokin

    1. Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany
    2. Cells-in-Motion Interfaculty Centre (CiMIC), University of Münster, Münster, Germany
    Contribution
    Supervision, Methodology, Writing - review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7704-7921

  8. Ralf H Adams

    1. Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, Münster, Germany
    2. Cells-in-Motion Interfaculty Centre (CiMIC), University of Münster, Münster, Germany
    Contribution
    Conceptualization, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing
    For correspondence
    ralf.adams@mpi-muenster.mpg.de
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3031-7677

Funding

Max-Planck-Gesellschaft

  • Ralf H Adams

University of Münster and the German Research Foundation (CRC1366A01)

  • Ralf H Adams

University of Münster and the German Research Foundation (CRC1009A02)

  • Ralf H Adams

University of Münster and the German Research Foundation (SO285/11-1)

  • Ralf H Adams

Cluster of Excellence 'Cells in Motion' (EXC1003)

  • Lydia Sorokin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

This work was supported by the Max Planck Society, the University of Münster and the German Research Foundation (DFG) CRC1366A01, CRC1009A02, SO285/11-1, and the Cluster of Excellence 'Cells in Motion' (EXC1003).

Ethics

All animal experiments were performed in compliance with the relevant laws and institutional guidelines, approved by local animal ethics committees, and conducted with permissions (84-02.04.2016.A525, 81-02.04.2020.A471 and 84-02.04.2017.A322) granted by the Landesamt für Natur, Umwelt und Verbraucherschutz (LANUV) of North Rhine-Westphalia, Germany. Every effort was made to minimize suffering.

Senior Editor

  1. Carla V Rothlin, Yale University, United States

Reviewing Editor

  1. Victoria L Bautch, University of North Carolina, Chapel Hill, United States

Publication history

  1. Received: April 2, 2020
  2. Preprint posted: June 13, 2022 (view preprint)
  3. Accepted: October 4, 2022
  4. Accepted Manuscript published: October 5, 2022 (version 1)
  5. Version of Record published: October 14, 2022 (version 2)

Copyright

© 2022, Jeong et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,816
    Page views
  • 862
    Downloads
  • 3
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hyun-Woo Jeong
  2. Rodrigo Diéguez-Hurtado
  3. Hendrik Arf
  4. Jian Song
  5. Hongryeol Park
  6. Kai Kruse
  7. Lydia Sorokin
  8. Ralf H Adams
(2022)
Single-cell transcriptomics reveals functionally specialized vascular endothelium in brain
eLife 11:e57520.
https://doi.org/10.7554/eLife.57520

Categories and tags

Research organism

Further reading

    1. Developmental Biology

    The Slingshot phosphatase 2 is required for acrosome biogenesis during spermatogenesis in mice

    Ke Xu, Xianwei Su ... Hongbin Liu
    Research Article Updated

    The acrosome is a membranous organelle positioned in the anterior portion of the sperm head and is essential for male fertility. Acrosome biogenesis requires the dynamic cytoskeletal shuttling of vesicles toward nascent acrosome which is regulated by a series of accessory proteins. However, much remains unknown about the molecular basis underlying this process. Here, we generated Ssh2 knockout (KO) mice and HA-tagged Ssh2 knock-in (KI) mice to define the functions of Slingshot phosphatase 2 (SSH2) in spermatogenesis and demonstrated that as a regulator of actin remodeling, SSH2 is essential for acrosome biogenesis and male fertility. In Ssh2 KO males, spermatogenesis was arrested at the early spermatid stage with increased apoptotic index and the impaired acrosome biogenesis was characterized by defective transport/fusion of proacrosomal vesicles. Moreover, disorganized F-actin structures accompanied by excessive phosphorylation of COFILIN were observed in the testes of Ssh2 KO mice. Collectively, our data reveal a modulatory role for SSH2 in acrosome biogenesis through COFILIN-mediated actin remodeling and the indispensability of this phosphatase in male fertility in mice.

    1. Developmental Biology
    2. Genetics and Genomics

    A timer gene network is spatially regulated by the terminal system in the Drosophila embryo

    Erik Clark, Margherita Battistara, Matthew A Benton
    Research Article Updated

    In insect embryos, anteroposterior patterning is coordinated by the sequential expression of the ‘timer’ genes caudal, Dichaete, and odd-paired, whose expression dynamics correlate with the mode of segmentation. In Drosophila, the timer genes are expressed broadly across much of the blastoderm, which segments simultaneously, but their expression is delayed in a small ‘tail’ region, just anterior to the hindgut, which segments during germband extension. Specification of the tail and the hindgut depends on the terminal gap gene tailless, but beyond this the regulation of the timer genes is poorly understood. We used a combination of multiplexed imaging, mutant analysis, and gene network modelling to resolve the regulation of the timer genes, identifying 11 new regulatory interactions and clarifying the mechanism of posterior terminal patterning. We propose that a dynamic Tailless expression gradient modulates the intrinsic dynamics of a timer gene cross-regulatory module, delineating the tail region and delaying its developmental maturation.

    1. Developmental Biology

    Kinetics of blood cell differentiation during hematopoiesis revealed by quantitative long-term live imaging

    Kevin Yueh Lin Ho, Rosalyn Leigh Carr ... Guy Tanentzapf
    Research Article

    Stem cells typically reside in a specialized physical and biochemical environment that facilitates regulation of their behavior. For this reason, stem cells are ideally studied in contexts that maintain this precisely constructed microenvironment while still allowing for live imaging. Here, we describe a long-term organ culture and imaging strategy for hematopoiesis in flies that takes advantage of powerful genetic and transgenic tools available in this system. We find that fly blood progenitors undergo symmetric cell divisions and that their division is both linked to cell size and is spatially oriented. Using quantitative imaging to simultaneously track markers for stemness and differentiation in progenitors, we identify two types of differentiation that exhibit distinct kinetics. Moreover, we find that infection-induced activation of hematopoiesis occurs through modulation of the kinetics of cell differentiation. Overall, our results show that even subtle shifts in proliferation and differentiation kinetics can have large and aggregate effects to transform blood progenitors from a quiescent to an activated state.